La vacuna adyuvada Heplisav-B induce alta respuesta inmune en VIH
Marks K, Kang M, Umbleja t et al. Immunogenicity and Safety of Hepatitis B vaccine with a Toll-like Receptor 9 Agonist Adjuvant (HEPLISAV-B) in HBV Vaccine-naive People with HIV. Clin Infect Dis published ahead of print April 5, 2023 https://academic.oup.com/cid/advance-article-abstract/doi/10.1093/cid/ciad201/7107372?redirectedFrom=fulltext&login=false Dada la respuesta subóptima a la vacuna recombinante tradicional de hepatitis B en personas VIH,…
Detalles

